跳至主要内容
临床试验/NCT02412813
NCT02412813撤回不适用

A Prospective, Randomized, Multi-Center, Metal Hypersensitivity Study Comparing OXINIUM and Cobalt Chrome Femoral Components in Failed Total Knee Arthroplasty

Smith & Nephew, Inc.5 个研究点 分布在 2 个国家开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
5
主要终点
Major modified Lymphocyte Transformation Tests (Cobalt, Chromium and Nickel) measurements

研究概览

简要总结

This is a prospective, randomized, multi-center, metal hypersensitivity study comparing OXINIUM and cobalt chrome femoral components in subjects with failed total knee arthroplasty (TKA).

详细描述

A total of 230 subjects will be randomized (1:1) to receive either an OXINIUM or cobalt chrome femoral components as part of their LEGION revision procedure. The objective of this study is to assess a lower serum metal ion concentration level in at least one of the three major mLTTs (Co, Cr or Ni) over 5 years in subjects receiving OXINIUM versus Cobalt Chrome femoral components as part of the LEGION Revision Total Knee System.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Subject is skeletally mature
  • Subject is willing to sign and date an IRB/EC approved consent form
  • Subject is a candidate for a revision knee replacement
  • Subject has met an acceptable preoperative medical clearance and is free or treated for cardiac, pulmonary, hematological, infection, or other conditions that would pose excessive operative risk
  • Subject agrees to adhere to the 10-year study visit schedule

排除标准

  • Subject with a known metal hypersensitivity
  • Subject requires a known bilateral revision TKA
  • Subject has severe pronation of the ipsilateral foot or any other relevant clinical condition contributing to abnormal ambulation
  • Subject has active infection or sepsis (treated or untreated)
  • Subject with an immunosuppressive disorder
  • Subject has presence of malignant tumor, metastatic, or neoplastic disease
  • Subject has conditions that may interfere with the TKA survival or outcome (i.e., Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease)
  • Subject has had intra-articular corticosteroid therapy (or any other intra-articular therapy) in the study knee within 3 months of study enrollment
  • Subject has inadequate bone stock to support the device and would require significant augmentation to correct the joint Female subject is of child-bearing age and unwilling to use an approved method of contraception
  • Subject has an emotional or neurological condition that would pre-empt their ability or willingness to comply with the study
  • Subject is severely overweight (BMI>40)
  • Subject is currently enrolled in another investigational drug, biologic, or device study or has been treated with an investigational product in the past 30 days
  • Subject is facing current or impending incarceration

结局指标

主要结局

Major modified Lymphocyte Transformation Tests (Cobalt, Chromium and Nickel) measurements

时间窗: 3,650 Days

Metal hypersensitivity will be concluded if at least one of these three measurements is statistically significant

次要结局

  • Revision of LEGION Revision Knee System for any reason at each post-surgical assessment(3,650 Days)
  • Changes in mean serum bio-markers from baseline to each subsequent assessment(3,650 Days)
  • Minor modified Lymphocyte Transformation Tests (Aluminum, Iron, Molybdenum, Vanadium and Zirconium)(3,650 Days)
  • Skin lesion evaluation to measure hypersensitivity(3,650 Days)
  • Anteroposterior, lateral and skyline knee views are assessed by radiographs(3,650 Days)
  • All adverse event reporting from surgery to 10 year post-surgery(3,650 Days)
  • Improves in mean 2011 Knee Society Score (2011 KSS) from baseline to each subsequent assessment(3,650 Days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验